External validation study of Re-SCORTEN in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Autor: Westmeijer M; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Utrecht University Medical School, Utrecht, The Netherlands., Ebriani J; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Thompson BB; Harvard Medical School, Boston, MA, USA., Holt A; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; University of Massachusetts Chan Medical School, Worcester, MA, USA., Brumbaugh B; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; University of Massachusetts Chan Medical School, Worcester, MA, USA., Ma KS; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA., Chen ST; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publikováno v: International journal of dermatology [Int J Dermatol] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.

Delays in diagnosis in cutaneous T-cell lymphoma: A retrospective study on clinical course and time to death.

Autor: Brumbaugh B; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts., Thompson B; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts., Holt A; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; University of Massachusetts Chan Medical School, Worcester, Massachusetts., Ebriani J; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; David Geffen School of Medicine at UCLA, Los Angeles, California., Perlman K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; University of Illinois College of Medicine, Chicago, Illinois., Patel C; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Jain S; Division of Hematology-Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Barnes J; Division of Hematology-Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Chen S; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: stchen@partners.org.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Nov; Vol. 91 (5), pp. 968-970. Date of Electronic Publication: 2024 Jul 14.

Impact of insurance status on treatment choice and hospitalization rates in bullous pemphigoid patients: a retrospective cross-sectional analysis.

Autor: Xiang DH; MGH Dermatology, Harvard Medical School, 50 Staniford Street, Ste. 200, 02114, Boston, MA, USA., Holt A; University of Massachusetts Chan Medical School, Worcester, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Thompson BB; MGH Dermatology, Harvard Medical School, 50 Staniford Street, Ste. 200, 02114, Boston, MA, USA., Ebriani J; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Brumbaugh B; MGH Dermatology, Harvard Medical School, 50 Staniford Street, Ste. 200, 02114, Boston, MA, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA., Reardon RM; MGH Dermatology, Harvard Medical School, 50 Staniford Street, Ste. 200, 02114, Boston, MA, USA., Chen ST; MGH Dermatology, Harvard Medical School, 50 Staniford Street, Ste. 200, 02114, Boston, MA, USA. stchen@mgb.org.; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA. stchen@mgb.org.

Publikováno v: Archives of dermatological research [Arch Dermatol Res] 2024 Aug 17; Vol. 316 (8), pp. 526. Date of Electronic Publication: 2024 Aug 17.

LB924 Evaluating the Impact of Dupilumab versus Systemic Immunosuppressant Therapy on Renal Outcomes in Moderate to Severe Atopic Dermatitis

Autor: Ma, K., Ebriani, J., Westmeijer, M., Brumbaugh, B., Holt, A., Chen, S.T.

Publikováno v: In Journal of Investigative Dermatology August 2024 144(8) Supplement:S162-S162

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.